Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Total Current Liabilities (2016 - 2025)

Marimed has reported Total Current Liabilities over the past 15 years, most recently at $59.1 million for Q4 2025.

  • Quarterly Total Current Liabilities rose 18.12% to $59.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.1 million through Dec 2025, up 18.12% year-over-year, with the annual reading at $59.1 million for FY2025, 18.12% up from the prior year.
  • Total Current Liabilities was $59.1 million for Q4 2025 at Marimed, up from $56.6 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $59.1 million in Q4 2025 and troughed at $14.6 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $32.5 million (2022), against an average of $35.4 million.
  • Year-over-year, Total Current Liabilities crashed 58.01% in 2021 and then soared 134.89% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $27.2 million in 2021, then dropped by 2.69% to $26.5 million in 2022, then increased by 16.5% to $30.9 million in 2023, then soared by 62.03% to $50.0 million in 2024, then rose by 18.12% to $59.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Total Current Liabilities are $59.1 million (Q4 2025), $56.6 million (Q3 2025), and $50.9 million (Q2 2025).